<IPO>TRANSTHERA-B (02617.HK) IPO Today; Entry Fee $6,641.31
Biopharmaceutical company TRANSTHERA-B (02617.HK) announced the details of its IPO, planning to ...
Biopharmaceutical company TRANSTHERA-B (02617.HK) announced the details of its IPO, planning to globally offer 15.281 million shares, with 10% for the Hong Kong public offering and 90% for the international offering.
The offer price per share was HKD13.15. Entry fee for each board lot (500 shares) was HKD6,641.31. The IPO starts today (13th) and will close at noon next Wednesday (18th), with the expected listing date on June 23. The joint sponsors are CITIC Securities and Huatai International.
The company introduced five cornerstone investors for the listing, including AKESO (09926.HK) , collectively subscribing to HKD130 million worth of company shares.
The company expected to raise net proceeds of approximately HKD161 million from the listing.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-12 16:25.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
